Company Filing History:
2 out of 905 
1 out of 1,327 
Years Active: 2007-2013
Title: Innovations by Inventor Markus Kuehn
Introduction
Markus Kuehn is an accomplished inventor based in Amana, Iowa. He has made significant contributions to the field of ocular drug delivery, holding 2 patents that focus on innovative methods for treating eye disorders. His work is characterized by a commitment to improving patient outcomes through advanced medical technologies.
Latest Patents
Kuehn's latest patents include groundbreaking research on sustained intraocular delivery of drugs from biodegradable polymeric microparticles. This patent describes biodegradable polymeric microparticle compositions that contain active agents useful for treating or preventing diseases of the eye. A preferred embodiment utilizes relatively hydrophilic, carboxylated polymeric materials such as PLGA to enhance drug loading for medications like timolol maleate, which is known for its water solubility. The invention aims to manage elevated intraocular pressure (IOP) effectively. Additionally, Kuehn has developed methods and compositions for treating ocular disorders such as retinal detachment and macular degeneration. These innovations also include techniques for diagnosing these conditions in patients.
Career Highlights
Throughout his career, Markus Kuehn has worked with prestigious institutions, including the University of Iowa Research Foundation and Yale University. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to significant advancements in ocular health.
Collaborations
Kuehn has collaborated with notable professionals such as Erin Lavik and Young H Kwon. These partnerships have fostered a rich environment for innovation and have led to the development of impactful medical solutions.
Conclusion
Markus Kuehn's contributions to ocular drug delivery exemplify the importance of innovation in medicine. His patents reflect a dedication to enhancing treatment options for patients with eye disorders. Through his work, Kuehn continues to pave the way for future advancements in the field.